Skip to main content

Health

Health and Life Sciences

Advance research and innovation in health and the life sciences through European funding programmes. We support universities, research organisations, healthcare providers, SMEs and industry in developing competitive projects across biotechnology, medical technologies, diagnostics, therapeutics, digital health, personalised medicine and advanced therapies. Our expertise spans Horizon Europe (Cluster 1 Health and EU Mission: Cancer), the Innovative Health Initiative (IHI), EDCTP3, EIC, MSCA and other European research and innovation programmes.

Ready to get started?

We provide expert support for every stage of your European research and innovation project.

Dr. Jeanette Müller

CEO

Horizon Europe Cluster 1 – Health

Cluster 1 – Health is part of Horizon Europe's Pillar II – Global Challenges and European Industrial Competitiveness, with a budget of around €8 billion for 2021–2027. It funds international collaborative projects that typically involve 10–25 partners, receive €5–15 million and typically run for 4–5 years. Involving six health destinations, the programme brings together universities, research organisations, hospitals, patient organisations, SMEs and industry to deliver innovation for healthy societies, environmental health, disease prevention and treatment, healthcare systems, health tools and technologies, and a competitive health industry.

EU Mission: Cancer

The EU Mission: Cancer is one of Horizon Europe's five EU Missions and supports ambitious research and innovation to improve the lives of more than 3 million people affected by cancer by 2030. Located under Pillar II, it funds international collaborative projects that typically involve 10–30 partners, receive €5–15 million and run for 4–5 years. Projects typically bring together universities, hospitals, research organisations, SMEs and industry to accelerate advances in cancer prevention, diagnosis, treatment and quality of life for patients and survivors.

MSCA Doctoral Networks (DNs)

MSCA Doctoral Networks (DNs) are Horizon Europe's flagship programme for doctoral training. They fund international research consortia that typically run for 4 years and fund 10–15 doctoral candidates through joint research, international mobility and cross-sector collaboration between universities, research organisations, SMEs and industry. DNs strengthen research excellence and support the development of future researchers addressing challenges in areas such as biomedical research, biotechnology, medical technologies and public health.

EIC Pathfinder Open & Challenges

The Pathfinder Open and Pathfinder Challenges funding instruments support the development of visionary, high-risk research with the potential to create transformative technologies. Projects typically receive €3–4 million in funding over 3–4 years. The Pathfinder Open scheme is fully bottom-up and allows applicants to propose breakthrough ideas from any scientific or technological field. Pathfinder Challenges, by contrast, are top-down calls focused on predefined strategic areas where Europe seeks technological leadership. Together, they foster interdisciplinary collaboration and help translate pioneering research into future innovations with significant societal and economic impact.

Innovative Health Initiative (IHI)

The Innovative Health Initiative (IHI) is a public-private partnership that supports collaborative research and innovation to address major health challenges and improve patient outcomes. It funds collaborative projects that typically involve 20–40 partners, receive €10–25 million and run for 4–6 years. IHI brings together industry, academia, healthcare providers, patients, and regulators to accelerate the development of safe, effective, and people-centred healthcare solutions. Through its calls for proposals, IHI promotes cross-sector collaboration to strengthen Europe's health innovation ecosystem and enhance global competitiveness.

Other European funding opportunities

Researchers and innovators in health and life sciences can access a wide range of European and national funding opportunities. These include more European Partnerships, ERC grants, EIT Health, EU4Health, COST Actions, EUREKA, ERA-NETs and national research programmes. We help you navigate this complex landscape and identify the funding instruments that best match your research objectives, innovation potential and long-term strategy.

Open Calls

Here some of the many EU funding opportunities we can help you succeed in.
HORIZON-HLTH-2027-01-DISEASE-08

Development of innovative antimicrobials against pathogens resistant to antimicrobials

Horizon Europe
Cluster 1 – Health
RIA
Deadline

17.02.2027, 17:00

Budget

€ 8 - 10 million

Single-stage

Our experience

See our track record in this area.
HORIZON-HLTH-2027-01-ENVHLTH-02

Integrating climate-related exposures into the human exposome and characterising its changes in response to climate change

Horizon Europe
Cluster 1 – Health
RIA
Deadline

17.02.2027, 17:00

Budget

€ 10 - 11 million

Single-stage

Our experience

See our track record in this area.
HORIZON-HLTH-2027-01-DISEASE-05

Development of novel small molecule antiviral therapeutics for pathogens with epidemic potential

Horizon Europe
Cluster 1 – Health
RIA
Deadline

17.02.2027, 17:00

Budget

€ 9 - 11 million

Single-stage

Our experience

See our track record in this area.

Project management

Our Project Management service supports international health research consortia throughout the entire project lifecycle, from grant preparation to final reporting. We coordinate governance, meetings, finances, reporting, risk management and communication with funding agencies, allowing researchers to focus on scientific excellence. Our team has supported more than 100 EU-funded projects, involving over 1,000 project partners and more than €300 million in collaborative research funding. Using accelCOCKPIT®, accelFINANCE® and accelINNO®, we ensure efficient project delivery, financial control and innovation management.

Project communication, dissemination and exploitation

Our Project Communication service helps health research projects maximise visibility, engage stakeholders and increase the impact of their results. We develop communication, dissemination and exploitation strategies, create websites and digital content, manage social media and organise workshops and stakeholder events. From patient engagement and clinical communities to policymakers and industry, we translate complex scientific results into clear messages that maximise project outreach and impact throughout and beyond the funding period.

Grant advice

Our grant funding advice service helps researchers, universities, hospitals, SMEs and companies identify the most suitable European and national funding opportunities for health and life science innovations. We assess project ideas, recommend the most appropriate funding instruments and support strategic grant planning to maximise funding potential. Using our proprietary accelGRANTS® platform, we systematically identify relevant calls and align them with your scientific objectives, technology readiness and long-term strategy. Whether you are considering MSCA Doctoral Networks, Horizon Europe Cluster 1, IHI, Cancer Missions or EIC Pathfinder, we help you make informed funding decisions and build a strong foundation for successful proposals.

Proposal writing

Our Proposal Writing service provides end-to-end support for health research consortia, from shaping a competitive project concept to delivering a high-quality proposal ready for submission. We translate scientific excellence into a compelling, evaluator-focused narrative by developing robust work plans, maximising impact pathways, designing credible implementation structures, coordinating partner contributions, and managing all administrative requirements. Supported by proven proposal templates and accelFINANCE® for structured budget development, we ensure every proposal is coherent, compliant, and strategically aligned with the call objectives. With success rates more than three times the European average, we help clients secure funding for ambitious, high-impact health research and innovation projects.

Training

Our Training courses help researchers, proposal writers and project managers develop the skills needed to secure and deliver successful research projects. We offer practical workshops on European funding opportunities, proposal writing, project management, communication and dissemination, as well as transferable skills modules for doctoral candidates and early-career researchers. Tailored to the needs of health and life science organisations, our training combines current funding requirements with hands-on experience from European collaborative projects, providing practical knowledge that participants can apply immediately.

What our clients say

“It is always a pleasure to work with the people from accelopment. In my experience they are dedicated, honest, and to the point.“

Prof. Menno Prins

CONSENSE Project Coordinator
Technical University Eindhoven, Netherlands

Programme:

H2020-MSCA-ITN

Duration:

01.03.2021 - 31.08.2025

Area:

Health, biosensing

Budget:

4.03 million euro

Frequently asked questions

Health research and innovation is supported through several European funding programmes and initiatives. Horizon Europe Cluster 1 Health is a major source of funding, complemented by instruments such as the EU Mission on Cancer and European Partnerships. Funding topics cover areas ranging from disease prevention, diagnosis and treatment to personalised medicine, digital health, healthcare systems and environmental influences on health. accelopment helps research organisations and companies identify suitable opportunities and develop competitive European research and innovation projects.

accelopment supports researchers and organisations throughout the development of Horizon Europe Health proposals. Depending on the consortium's needs, this can include analysing the call topic, developing the proposal strategy and structure, coordinating contributions from consortium partners, supporting proposal writing and reviewing the application against Horizon Europe evaluation criteria. Particular attention is given to the project's expected outcomes and impacts, implementation approach and measures for communication, dissemination and exploitation. The objective is to turn a strong scientific concept into a coherent and convincing European research and innovation proposal.

accelopment supports collaborative European research and innovation projects addressing a broad range of health and life sciences challenges. These include areas such as cancer, infectious and chronic diseases, personalised medicine, diagnostics, medical technologies, digital health, patient-centred care and the environmental determinants of health. Our role complements the scientific and clinical expertise of project partners with expertise in EU funding, proposal development, project management, communication, dissemination, exploitation and innovation management.

Communication, dissemination and exploitation help translate health research into benefits for patients, healthcare professionals, policymakers, industry and society. A strong strategy identifies the project's different target groups, defines how results will be shared with them and establishes pathways for the uptake and use of those results. In health projects, this can include scientific dissemination, stakeholder and patient engagement, policy communication, exploitation of technologies or methodologies and support for clinical or market-oriented pathways. These activities contribute directly to the credibility of the project's expected impact.

Yes. accelopment supports EU-funded research and innovation projects during implementation as well as during proposal development. Depending on the project, this can include project management and coordination support, internal consortium processes, reporting, communication and dissemination, stakeholder engagement, exploitation activities and innovation management. Having these functions professionally managed helps scientific and clinical partners concentrate more of their resources on research and innovation activities while maintaining compliance with Horizon Europe requirements.
©accelopment Schweiz AG
+41 44 455 66 00 
info@accelopment.com  
ISO 9001 certified
© 2026 accelopment. All rights reserved.